Stay updated with breaking news from Presentation Title. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oral Presentation to Highlight AMT-191 for Fabry DiseaseLEXINGTON, Mass. and AMSTERDAM, The Netherlands, Oct. 19, 2021(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for
MAINZ, Germany, October 1, 2021(Nasdaq: BNTX, "BioNTech" or "the Company"), a next generation immunotherapy company pioneering novel therapies for cancer and infectious diseases, today announced that new
Investegate announcements from Carrick Therapeutics, Carrick Therapeutics to Present First Clinical Data on Samuraciclib (CT-7001), a First-In-Class Inhibitor of CDK7 at the European Society for Medical Oncology (ESMO) Congress 2021
Published: Jun 09, 2021 NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming data presentations at the 16 th International Congress on Malignant Lymphoma (ICML), being held virtually June 18 – 22, 2021. Details of the data presentations are included below. Poster Presentation Title : TG-1701, A Selective Bruton Tyrosine Kinase (BTK) Inhibitor, as Monotherapy and in Combination with Ublituximab and Umbralisib (U2) in Patients with B-cell Malignancies Abstract Book Number: 236 Presentation Available on Demand: Friday, ...
/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that three abstracts highlighting data and...